Post by Vertical

At the Reuters Events Pharma Barcelona, everyone is debating agentic AI workflows and advanced use cases. Meanwhile, most pharma companies still can’t get their first-line teams to use basic AI tools consistently. Our takeaway from 3 years of driving implementation of AI tools? 💎 Scaling AI starts not with tech but organizational design. You can deploy the fanciest models, but if your role structures and incentives haven’t moved, adoption stalls. Change leadership and systematic upskilling aren’t nice-to-haves. They are the whole game. 👥 Stop framing this as tools vs. humans. Agentic workflows should augment roles, not replace them. A Medical Affairs team with AI handling research synthesis and evidence cataloging? That’s not displacement, it’s freeing humans to do the thinking that actually requires judgment and relationships. And the question isn’t whether workflows replace people, but whether people learn to work differently. ✨ Move past the email-writing use case for AI, for real. Role-specific task augmentation is where the real value lives. What does a Brand Manager's decision-making actually look like when 70% of content research is automated? What changes for a Regulatory Affairs team when they can interrogate submissions at scale? That's the conversation we should be having. Future winners aren't chasing the newest models, they’re building a foundation of deep, role-specific AI adoption across the organisation today. #REpharma #AI #Leadership